Home - Products - Others - Other Targets - Aurantioobtusin 2-O-β-D-glucopyranoside

Aurantioobtusin 2-O-β-D-glucopyranoside

CAS No. 439086-30-3

Aurantioobtusin 2-O-β-D-glucopyranoside( ——— )

Catalog No. M38244 CAS No. 439086-30-3

Aurantioobtusin 2-O-β-D-glucopyranoside

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
25MG Get Quote Get Quote
50MG Get Quote Get Quote
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Aurantioobtusin 2-O-β-D-glucopyranoside
  • Note
    Research use only, not for human use.
  • Brief Description
    Aurantioobtusin 2-O-β-D-glucopyranoside
  • Description
    Aurantioobtusin 2-O-β-D-glucopyranoside
  • In Vitro
    ———
  • In Vivo
    ———
  • Synonyms
    ———
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    ———
  • Research Area
    ———
  • Indication
    ———

Chemical Information

  • CAS Number
    439086-30-3
  • Formula Weight
    ———
  • Molecular Formula
    ———
  • Purity
    >98% (HPLC)
  • Solubility
    ———
  • SMILES
    ———
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Thalifendine

    Thalifendine is a metabolite of Berberine, with antiplasmodial and antiamoebic activities.

  • H-Phe(4-Cl)-D-Cys-β-...

    PRL 3195 is a somatostatin receptor antagonist with Kis of 6, 17, 66, 1000 and 1000 nM for human somatostatin receptors (sst5, sst2, sst3, sst1 and sst4, respectively).

  • BI-0474

    BI-0474 is a potent KRASG12C inhibitor that inhibits GDP-KRAS::SOS1 protein-protein interactions with an IC50 value of 7.0 nM.BI-0474 exhibits significant antiproliferative activity against NCI-H358 cells harboring the G12C mutation, and shows significant anti-tumor activity in a non-small cell lung cancer xenograft model.